课题基金 / 基金详情

Predictive Treatment Response Models for Epithelial Ovarian Cancer: Comparison between 2D, 3D, and in vivo Models

Predictive Treatment Response Models for Epithelial Ovarian Cancer: Comparison between 2D, 3D, and in vivo Models
上皮性卵巢癌的预测治疗反应模型：2D、3D 和体内模型之间的比较
批准号：
411808
负责人：
Brodeur Melica Nourmoussavi
金额：
$0.07万
依托单位：
Institut du cancer de Montral
依托单位国家：
加拿大
项目类别：
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2020-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=411808&lang=en
关键词：
Ics Travel Award

项目摘要

项目成果

Brodeur Melica Nourmoussavi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer is still a deadly disease and much of the drug discoveries in the field rely on preclinical models, the most common being in vitro models. 2D systems are often used due to cost and time efficiency, but may not reflect true patient response
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predictive Models for Carboplatin with or without Hyperthermia Treatment Response in Epithelial Ovarian Cancer: Comparison of 2D, 3D, and in-vivo Models
  • 批准号：
    406473
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2018
  • 负责人：
    Brodeur Melica Nourmoussavi
  • 依托单位：
    Universit de Montral